News & Events

September 28, 2003

3rd Nobel Pauling Biotech Symposium
Academia vs. Industry for New drug discovery

In honor of the Life and Works of Dr. Linus Pauling. Dr. Pauling won two Nobel Prizes- in 1954 for Chemistry and in 1962 for Peace.

Click here to see photos from this event

Date: Sunday, September 28, 2003
10:00 am - 9:00 pm (free parking on Sunday at Sloan & Hayward parking lots)
Location: MIT Faculty Club. 50 Memorial Drive - 6th Floor, Cambridge, MA (directions)
Organizer: Student Vision (
Exhibition Booth and Buffet: 10:00 am - 9:00 pm
Gifts from Dr. Linus Pauling, Jr. for all speakers
Sponsors: Major sponsors are ActoKine, LRIG , Aventis & InnoCentive, plus 30+ others

MIT Dim Sum for Nobel Pauling Biotech Symposium

Booth set up, Registration, and Booth Exhibition
Welcome: Grace Wong, PhD ActoKine Therapeutics
Education Talk: Jennifer Shore, Stem Cell Technologies
Power Pitch: Marsha Paul, LRIG
Smart Pitch from Participants
(Moderators: Ronald E. Vincent, ISTCP Scientific)
Speaker: Martin A. Wasserman, PhD, AtheroGenics
Title: AGI-1067: An Innovative V-Protectant for Treating Atherosclerosis and Coronary Artery Disease.
Sponsor Pitch, Magic Pitch, Idea Pitch, Tech Pitch & Power Pitch
(Moderators: Dean Remy, Li-Cor Inc., and Kathleen Hehir, PhD, TranXenoGen Inc.)
Networking, Booth Exhibition & Buffet Lunch
Francis Xavier Farrell, PhD, Johnson & Johnson (Buffet Lunch)
Title: Non-Hematopoietic Effects of Erythropoietin.
Chair: Raul Krauss, PhD, ActoKine Therapeutics
Speaker: Dinah W. Sah, PhD, Biogen
Title: Overview of Neublastin.
Smart Pitch, Moderators: Danielle Morin, Rainin Inc and Sonia Sparks Wallman, PhD NH Biotech Council
Networking and Booth Exhibition
Speaker: Amy L. Rubinstein, PhD Zygogen
Title: Discovering Angiogenesis Compounds and Targets with Z-Tag
Chair: Dyke Hendrickson, Mass High Tech
Speaker: King Li, MD, NIH Clinical Center
Title: Angiogenesis Imaging: Current Status and Future Outlooks (Buffet Dinner)
Chair: Mika Newton, Tripos Inc.
Speaker: Zhenping Zhu, MD, PhD ImClone
Title: Inhibition of VEGF Activities with Antibodies Directed against its Kinase Receptors
Panel discussion: Academia vs. Industry for New Drug Discovery
Seth Cohen, PhD LRIG & Deam Remy, Li-Cor
Chair: Michael Belanger, SemanTx Life Sciences
Speaker: Hans-Peter Gerber, PhD Genentech
Title: Avastin (Bevacizumab) prolongs survival in first-line colorectal cancer treatment
Chair: Kathy Seidl, Suntory Pharmaceuticals
Speaker: Steve Wiley, PhD Amgen
Title: The TWEAK-Tweak® Signaling Pathway Coordinates Angiogenesis, Tissue Growth and Induction of Pro-Inflammatory Cytokines
Concluding Remarks by Jim Dasch, PhD ActoKine Therapeutics

Jennifer Shore
Marsha Paul, PhD
Dyke Hendrickson
Amy Rubinstein, PhD

Francis Xavier Farrell, PhD
Martin Wasserman, PhD
King Li, MD, PhD
Zheping Zhu, MD, PhD

Panel Discussion
Industry Speakers:

 • Aventis (Amar Drawid, PhD)
 • Amgen (Steve Wiley, PhD)
 • Ariad Pharmaceuticals (Roy Pollock, PhD)
 • Novartis (Yong Yao Xu, Jeanette Wood, PhD)
 • Genentech (Hans-Peter Gerber, PhD)
 • Serono (Deanne Taylor PhD)
 • Wyeth (Jun Jun Wu, PhD)
 • Genpath Pharmaceuticals (Geoff Boynton)

Academic Speakers:
 • NIH (King Li, MD)
 • MIT (Shuguang Zhang, PhD)
 • Whitehead Institute (Shailendra Yadav, PhD)
 • UMass Medical School (Irene Bosch, PhD)
 • MIT (Bobak Azamian, PhD)
 • Harvard Medical School (Mikhail Semenov, PhD)

Home | Mission | Registration | Sponsors | Job Strategies | News, Events, Contact

Biotech Booth | Event Photos | Nobel Day | Dr. Linus Pauling | Who's Who

Pauling Biotech Symposium | Symposium Agenda | Symposium Speakers | Symposium Testimonials

Founder & Board of Directors | Scientific Advisory Committee | Scholarship Application

copyright 2004